Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The unmet need of evidence-based therapy for patients with advanced chronic kidney disease and heart failure: Position paper from the Cardiorenal Working Groups of the Spanish Society of Nephrology and the Spanish Society of Cardiology.
Ortiz A, Navarro-González JF, Núñez J, de la Espriella R, Cobo M, Santamaría R, de Sequera P, Díez J. Ortiz A, et al. Among authors: de la espriella r, de sequera p. Clin Kidney J. 2021 Dec 23;15(5):865-872. doi: 10.1093/ckj/sfab290. eCollection 2022 May. Clin Kidney J. 2021. PMID: 35498889 Free PMC article.
Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients.
Goicoechea M, Sanchez-Niño MD, Ortiz A, García de Vinuesa S, Quiroga B, Bernis C, Morales E, Fernández-Juarez G, de Sequera P, Verdalles U, Verde E, Luño J. Goicoechea M, et al. Among authors: de sequera p. Prostaglandins Leukot Essent Fatty Acids. 2017 Oct;125:8-13. doi: 10.1016/j.plefa.2017.08.009. Epub 2017 Aug 24. Prostaglandins Leukot Essent Fatty Acids. 2017. PMID: 28987723 Clinical Trial.
Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study).
Goicoechea M, de Vinuesa SG, Quiroga B, Verde E, Bernis C, Morales E, Fernández-Juárez G, de Sequera P, Verdalles U, Delgado R, Torres A, Arroyo D, Abad S, Ortiz A, Luño J. Goicoechea M, et al. Among authors: de vinuesa sg, de sequera p. Cardiovasc Drugs Ther. 2018 Jun;32(3):255-263. doi: 10.1007/s10557-018-6802-1. Cardiovasc Drugs Ther. 2018. PMID: 29943364 Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 33892978
Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study.
Quiroga B, Soler MJ, Ortiz A, Martínez Vaquera S, Jarava Mantecón CJ, Useche G, Sánchez Márquez MG, Carnerero M, Jaldo Rodríguez MT, Muñoz Ramos P, Ruiz San Millán JC, Toapanta N, Gracia-Iguacel C, Aguilar Cervera MC, Balibrea Lara N, Leyva A, Rojas J, Gansevoort RT, de Sequera P; SENCOVAC Collaborative Network. Quiroga B, et al. Among authors: de sequera p. Nephrol Dial Transplant. 2022 Sep 22;37(10):1868-1878. doi: 10.1093/ndt/gfab313. Nephrol Dial Transplant. 2022. PMID: 34788858 Free PMC article.
Loss of humoral response 3 months after SARS-CoV-2 vaccination in the CKD spectrum: the multicentric SENCOVAC study.
Quiroga B, Soler MJ, Ortiz A, Bernat A, Muñoz Díaz AB, Jarava Mantecón CJ, Gómez Pérez VO, Calderón González C, Cervienka M, Mazuecos A, Cazorla JM, Carnerero Di Riso M, Martínez S, Ortega Diaz M, Lucena Valverde R, Sánchez Márquez MG, Lancho Novillo C, González Parra E, Gracia-Iguacel C, Rodrigo De Tomas MT, Aguilar Cervera MC, Giorgi M, Muñoz Ramos P, Macías Carmona N, Toapanta N, Cigarrán S, Ruiz San Millán JC, Santana Estupiñán R, Crespo M, Villacorta Linaza B, Jimeno Martín MI, Rodríguez-Osorio Jiménez L, Soriano S, González Ferri D, Pizarro Sánchez MS, Yugueros A, Leyva A, Rojas J, Gansevoort RT, de Sequera P; SENCOVAC collaborative network. Quiroga B, et al. Among authors: de sequera p. Nephrol Dial Transplant. 2022 Apr 25;37(5):994-999. doi: 10.1093/ndt/gfac007. Nephrol Dial Transplant. 2022. PMID: 35022757 Free PMC article. No abstract available.
105 results